HS-IT101 Injection in the Treatment of Advanced Melanoma
Clinical trial NCT06941818 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06941818
- Sponsor
- Qingdao Sino-Cell Biomedicine Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2026-05-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.